2021
DOI: 10.1016/j.jss.2020.09.017
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Protocol Utilizing Water-Soluble Contrast for Adhesive Small Bowel Obstruction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(9 citation statements)
references
References 18 publications
0
9
0
Order By: Relevance
“…Gastrografin was used as the WSC agent in all RCTs and observational studies other than those by Yagci (Urografin Guerbet, Princeton, NJ)31 and Dombert (MD-Gastroview) 28. The timing of WSC was inconsistent across studies.…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…Gastrografin was used as the WSC agent in all RCTs and observational studies other than those by Yagci (Urografin Guerbet, Princeton, NJ)31 and Dombert (MD-Gastroview) 28. The timing of WSC was inconsistent across studies.…”
Section: Resultsmentioning
confidence: 99%
“…20 Other WSC agents, including Urografin and MD-Gastroview are solutions of varying concentrations of the same compounds, demonstrating similar hyperosmotic properties. 28,31 An important limitation of the WSC treatment of aSBO body of literature is the lack of standardization of protocols between studies. Some, but not all, of the studies involved the placement of an NGT shortly after hospital admission.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations